Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA: 600222)
China
· Delayed Price · Currency is CNY 5.18
-0.10 (-1.89%)
Dec 25, 2024, 3:00 PM CST
Henan Taloph Pharmaceutical Stock Co.,Ltd Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 89.38 | 43.56 | -72.2 | 6 | 29.24 | 44.41 | Upgrade
|
| Depreciation & Amortization | 67.51 | 67.51 | 62.98 | 57.18 | 41.42 | 38.18 | Upgrade
|
| Other Amortization | 8.18 | 8.18 | 4.95 | 3.31 | 5 | 4.93 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.62 | -0.62 | -0.07 | - | -0.54 | -0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.08 | 0.08 | -0.1 | 1.57 | 0.34 | 2.62 | Upgrade
|
| Loss (Gain) From Sale of Investments | 6.42 | 6.42 | 11.87 | 6.52 | -7.05 | -8.16 | Upgrade
|
| Provision & Write-off of Bad Debts | 11.86 | 11.86 | 33.81 | 25.54 | 12.53 | 15.13 | Upgrade
|
| Other Operating Activities | -42.63 | 47.22 | 65.17 | 91.74 | 80.05 | 81.33 | Upgrade
|
| Change in Accounts Receivable | -3.07 | -3.07 | -380.27 | -130.93 | -9.23 | -123.93 | Upgrade
|
| Change in Inventory | -7.38 | -7.38 | -70.61 | -37.3 | -51.35 | -8.98 | Upgrade
|
| Change in Accounts Payable | -123.27 | -123.27 | 231.57 | 82.8 | -23.83 | 0.56 | Upgrade
|
| Operating Cash Flow | -0.29 | 43.74 | -124.41 | 99.66 | 73.43 | 41.53 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | 35.72% | 76.82% | -65.24% | Upgrade
|
| Capital Expenditures | -22.99 | -43.13 | -66.62 | -39.07 | -72.65 | -107.68 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.12 | 0.22 | 0.19 | 0.06 | 0.08 | 0.1 | Upgrade
|
| Divestitures | 0.85 | 1.8 | 0.2 | 0.57 | - | 27.12 | Upgrade
|
| Investment in Securities | -1.49 | -164 | 137.25 | -87.67 | -120.17 | -51.88 | Upgrade
|
| Other Investing Activities | 6.02 | 55.1 | 63.1 | 25.96 | 2.09 | 1.96 | Upgrade
|
| Investing Cash Flow | -17.49 | -150.02 | 134.12 | -100.16 | -188.85 | -129.38 | Upgrade
|
| Long-Term Debt Issued | - | 1,076 | 950.09 | 1,298 | 1,104 | 910.12 | Upgrade
|
| Long-Term Debt Repaid | - | -938.41 | -1,403 | -1,381 | -982.48 | -913.1 | Upgrade
|
| Net Debt Issued (Repaid) | 370.65 | 137.3 | -452.6 | -82.27 | 121.69 | -2.98 | Upgrade
|
| Issuance of Common Stock | 34.46 | 34.46 | 137.17 | 95.16 | 26.82 | - | Upgrade
|
| Repurchase of Common Stock | -42.07 | -42.07 | -37.66 | -45.48 | - | -126.31 | Upgrade
|
| Common Dividends Paid | -70.99 | -50.17 | -63.51 | -84.56 | -65.47 | -60.54 | Upgrade
|
| Other Financing Activities | -91.15 | -52.97 | 331.37 | -39.44 | 126.53 | 1.83 | Upgrade
|
| Financing Cash Flow | 200.91 | 26.56 | -85.23 | -156.58 | 209.57 | -187.99 | Upgrade
|
| Net Cash Flow | 183.13 | -79.72 | -75.51 | -157.08 | 94.15 | -275.84 | Upgrade
|
| Free Cash Flow | -23.28 | 0.6 | -191.03 | 60.58 | 0.77 | -66.15 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 7717.75% | - | - | Upgrade
|
| Free Cash Flow Margin | -1.18% | 0.03% | -9.74% | 3.78% | 0.05% | -5.04% | Upgrade
|
| Free Cash Flow Per Share | -0.04 | 0.00 | -0.34 | 0.11 | 0.00 | -0.12 | Upgrade
|
| Cash Interest Paid | 0.8 | 0.8 | 3.73 | 4.54 | 2.48 | - | Upgrade
|
| Cash Income Tax Paid | 66.95 | 84.4 | 59.53 | 51 | 49.86 | 52.3 | Upgrade
|
| Levered Free Cash Flow | -74.41 | -99.01 | 361.28 | 127.37 | -35.35 | -62.18 | Upgrade
|
| Unlevered Free Cash Flow | -38.93 | -65.03 | 401.67 | 179.77 | 11.18 | -19.31 | Upgrade
|
| Change in Net Working Capital | 158.17 | 145.05 | -405.28 | -80.01 | 10.23 | 27.75 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.